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Abstract 
Background: Systematic reviews and meta-analyses that do not include unpublished data in their analyses may be 
prone to publication bias, which in some cases has been shown to have deleterious consequences on determining 
the efficacy of interventions.
Methods: We retrieved systematic reviews and meta-analyses published in the past 8 years (January 1, 2007–
December 31, 2015) from the top 20 journals in the Pregnancy and Childbirth literature, as rated by Google Scholar’s 
h5-index. A meta-epidemiologic analysis was performed to determine the frequency with which authors searched 
clinical trials registries for unpublished data.
Results: A PubMed search retrieved 372 citations, 297 of which were deemed to be either a systematic review or a 
meta-analysis and were included for analysis. Twelve (4 %) of these searched at least one WHO-approved clinical trials 
registry or clinicaltrials.gov.
Conclusion: Systematic reviews and meta-analyses published in pregnancy and childbirth journals do not routinely 
report searches of clinical trials registries. Including these registries in systematic reviews may be a promising avenue 
to limit publication bias if registry searches locate unpublished trial data that could be used in the systematic review.
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Background
A systematic review is a form of research synthesis that 
brings together all available evidence using pre-determined 
methodologies to address a specific research question 
[1]. These reviews, when appropriate, may contain one or 
more meta-analyses whereby effect sizes from primary 
studies are combined statistically to produce a pooled 
effect estimate. For example, a recent systematic review 
of ten primary studies noted a twofold increase in peri-
natal depression in women with unexpected pregnancies 
[2]. Awareness of the association between depression and 
unplanned pregnancies can serve to lower clinical thresh-
old for detection of depressive symptoms in new mothers, 
which can lead to timely and appropriate intervention. As 
such, systematic reviews and meta-analyses have the poten-
tial to ameliorate clinical practice and are of particular 
importance in a rapidly evolving specialty of pregnancy and 
childbirth.
While well-conducted systematic reviews are often 
considered the gold standard for determining care 
guidelines, they are susceptible to bias. One particular 
bias, known as publication bias, occurs when systematic 
reviews are comprised only of published studies with sta-
tistically significant outcomes. This bias likely misrepre-
sents the true effectiveness of an intervention since only 
results showing significant differences are included. For 
instance, a study by Hart and colleagues [3] assessed sys-
tematic reviews and meta-analysis carried out on nine 
medications that were approved by the FDA in a sin-
gle year: 2001. They found that when unpublished data 
were incorporated in these reviews, only 7  % of these 
meta-analyses predicted the drug in question to have 
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the same efficacy. In other words, over 90 % of the sys-
tematic reviews carried out to make clinical decisions 
on interventions were incorrect as a result of publication 
bias. Publication bias is a known problem in maternal-
foetal medicine research [4], and perinatology research-
ers should take precaution to limit this form of bias from 
systematic reviews. In a high pressure and high litigation 
field such as pregnancy and childbirth, where knowledge 
of the most current research advances is expected, the 
importance of highest quality evidence-based medicine 
cannot be overstated.
The primary means to limit publication bias is to use 
comprehensive and far-reaching search strategies to 
identify unpublished and non-significant data. While 
many data sources have been proposed, perhaps the 
most promising is to use clinical trials registries to locate 
unpublished trial data. These registries have been created 
across the globe, and the rate of clinical trial registrations 
is on the rise. For example, ClinicalTrials.gov received 
206,176 registrations in 2015 alone [5]. In other words, 
this website receives 25 registrations per hour, 24 h per 
day, 365 days per year.
This astonishing volume of registrations is explained, 
in large part, by passage of section 801 of the Food and 
Drug Administration Amendment Act (FDAAA), which 
legally obligates registration of clinical trials meeting one 
or both of the following criteria prior to commencement 
of the trial:
“1. Trials of drugs and biologics: Controlled clinical 
investigations, other than phase 1 clinical investiga-
tions, of drugs or biological products subject to Food 
and Drug Administration (FDA) regulation.
2. Trials of devices: 1) Controlled trials with health 
outcomes of devices subject to FDA regulation, other 
than small feasibility studies, and 2) pediatric post-
market surveillance required by FDA”.
Despite the large number of registered clinical trials 
and strong recommendations from the Cochrane Col-
laboration to search trials registries for unpublished data, 
recent evidence suggests limited use of registries by sys-
tematic reviewers [6–9].
Here, we examine the prevalence of use of clinical trials 
registries searches by systematic reviewers in pregnancy 
and prenatal health journals. We also catalogue the spe-
cific registries searched and whether unpublished trial 
data were successfully found and/or incorporated into 
the systematic review findings. Finally, we examine the 
temporal trend of clinical trials registry searches over the 
past 8 years since passage of the FDA Amendments act 
mandated the registration of most clinical trials involving 
human patients prior to commencement.
Methods
Study design
This was a meta-epidemiologic systematic review, and thus 
registration with the international prospective register of 
systematic reviews (PROSPERO) did not apply. We identi-
fied the top 20 journals in the Pregnancy and Childbirth 
subspecialty of health and medical sciences using Google 
Scholar’s h5-index, which rates journals based on their “vis-
ibility and influence” [10]. Briefly, h5-index is an alternative 
to the traditional rating of scientific journals based on their 
“impact factor”, which takes into account the number of 
times an article is cited vs. the number of publication a jour-
nal produces [11]. The top 20 highest-rated journals in Preg-
nancy and Childbirth were searched for systematic reviews 
and meta-analyses published between January 1, 2007 and 
December 31, 2015. A search strategy was developed for 
high sensitivity and designed through collaboration with a 
National Institutes of Health medical librarian. The search 
was performed on December 29, 2015 and deployed as fol-
lows: ((((((((((((((((((((((((“Archives of disease in childhood. 
Fetal and neonatal edition”[Journal])) OR (“BMC pregnancy 
and childbirth”[Journal])) OR “Seminars in fetal & neonatal 
medicine”[Journal]) OR (“The journal of maternal-fetal & 
neonatal medicine: the official journal of the European Asso-
ciation of Perinatal Medicine, the Federation of Asia and Oce-
ania Perinatal Societies, the International Society of Perinatal 
Obstetricians”[Journal])) OR “Journal of perinatology: offi-
cial journal of the California Perinatal Association”[Journal]) 
OR (“Maternal and child health journal”[Journal])) OR 
(“Birth defects research. Part A, Clinical and molecular 
teratology”[Journal])) OR “Midwifery”[Journal]) OR “Semi-
nars in perinatology”[Journal]) OR (“Paediatric and peri-
natal epidemiology”[Journal])) OR (“Fetal diagnosis and 
therapy”[Journal])) OR “Clinics in perinatology”[Journal]) 
OR “American journal of perinatology”[Journal]) OR “Jour-
nal of perinatal medicine”[Journal]) OR “Maternal & child 
nutrition”[Journal]) OR “Birth (Berkeley, Calif.)”[Journal]) 
OR “Birth defects research. Part C, Embryo today: 
reviews”[Journal]) OR “Journal of midwifery & women’s 
health”[Journal]) OR (“Journal of obstetric, gynecologic, 
and neonatal nursing: JOGNN/NAACOG”[Journal])) OR 
“Journal of human lactation: official journal of International 
Lactation Consultant Association”[Journal]) AND (((meta-
analyses[Title/Abstract] OR meta-analysis[Title/Abstract] 
OR “meta analyses”[Title/Abstract] OR “meta analysis”[Title/
Abstract] OR meta analyses[Title/Abstract] OR 
metaanalysis[Title/Abstract]) OR “systematic review”[Title/
Abstract]) OR meta-analysis[Publication Type])) AND 
(“2007/01/01”[Date—Publication]: “2015/12/31”[Date—
Publication])) AND “humans”[MeSH Terms]) NOT ((let-
ter [pt] OR newspaper article [pt])). A more detailed search 
string, formatted in accordance with guidelines described in 
the Cochrane Handbook of Systematic reviews is publically 
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available online (see “Availability of data and materials” 
section).
Data extraction and training
Articles were retrieved using the search string above. 
Citations were imported and full text articles were 
retrieved using EndNote™ (Version X7). Each article 
not retrieved using this method was manually obtained 
by the authors through the home institution’s library 
subscriptions.
A training session was conducted during which a set of 
detailed steps for systematic data collection and analysis 
was explained and demonstrated to the team. The data 
of interest included the full names and abbreviations of 
each of the clinical trials registries. The methodology, 
which was based on searching each full text using the 
“Find” function, was verified against previously published 
data [9] and achieved 100 % accuracy, as compared to the 
original study.
Screening and outcome measures
The authors (VY and BC) screened the title and abstract 
of all retrieved articles (N  =  372) to determine if the 
citation met the criteria of a systematic review or meta-
analysis. For the citations that likely did not meet the 
criteria, or if it was unclear whether or not the criteria 
were met, the full text of the study in question was care-
fully reviewed. Any disagreements were settled through 
a discussion between the authors. An article was clas-
sified as a systematic review if it met previously estab-
lished criterion; specifically, articles were included if (1) 
the authors provided clear inclusion/exclusion criteria 
for the selected studies and (2) the authors attempted 
to perform a comprehensive search of the available lit-
erature on a pre-determined topic. A more detailed 
discussion on what constitutes a systematic reviews 
or meta-analysis can be found in previously published 
work [1, 12, 13].
Analogous to current publications on the topic [6, 8, 
9], we chose to limit our search to the 16 World Health 
Organization (WHO)-approved registries given the 
stringent requirements for clinical trial registration 
maintained by these registries. We also included Clini-
calTrials.gov, as it appears to be the most frequently 
searched clinical trials registry [6, 9]. The methods sec-
tions and any supplementary materials of each of the 
studies mentioning these clinical trials registries were 
carefully reviewed by Yerokhin and Carr to determine 
if the registry was searched, if usable data were found, 
and if the data were used for analysis in the publication. 
Finally, we chose to exclude Cochrane Central Register of 
Controlled Trials (CENTRAL) [14], as it is a collection of 
published clinical trials rather than a trials registry.
With help of medical librarians (JC and MF), we also 
checked whether or not applicable data were available 
on trials registry databases by searching for specific trials 
using the keywords provided by the systematic review-
ers. This was accomplished by randomly choosing 26 
systematic reviews and meta-analyses from our dataset 
of 297 studies (see below) included for analysis. Rand-
omized selection was performed using the random num-
ber generator in Microsoft Excel. Two separate queries 
were deployed: one through clinicaltrials.gov and another 
through WHO-approved registries. The data were con-
sidered to be available, when a search query returned 
clinical trials with available data prior to publication of 
the review (e.g. if a review was published in 2014, only 
trials with data available on, or before, 2013 were consid-
ered applicable). This study’s protocol and manuscript 
creation was carried out in accordance to all applicable 
Preferred Reporting Items for Systematic Reviews and 
Meta-analyses (PRISMA) [15] guidelines.
Results
Our PubMed search yielded a total of 372 articles pub-
lished between January 1, 2007 and December 31, 2015. 
Of these, 297 publications were included for analysis 
(Fig. 1). A total of 75 studies were excluded from analysis 
because they either did not meet the criteria of a system-
atic review, or performed a pooled analysis of primary 
data from disease-specific databases. The main, coded 
dataset is publically available online (see “Availability of 
data and materials” section).
Clinical trials registry search by journal
The frequency of clinical trials registry searches was 
determined for each publication within the correspond-
ing journal. Systematic reviews and meta-analyses pub-
lished in BMC Pregnancy and Childbirth, Paediatric 
Perinatal Epidemiology, Journal of Maternal Fetal and 
Neonatal Medicine, Archives of Disease in Childhood: 
Fetal and Neonatal Edition and American Journal of 
Perinatology searched clinical trials registries most fre-
quently. A total of 3 of 46 articles in BMC Pregnancy 
and Childbirth, 2 of 26 in Journal of Maternal Fetal and 
Neonatal Medicine, 2 of 23 articles in American Journal 
of Perinatology, and 1 of 34 in Paediatric Perinatal Epi-
demiology reported searches of clinical trials registries as 
part of the systematic review process. Systematic reviews 
retrieved from 12 of the 19 journals searched neither 
ClinicalTrials.gov, nor any of the 16 WHO-approved 
clinical trials registries (Fig. 2).
Use of clinical trials registry data
We reviewed each study that searched any of the 17 clini-
cal trials registries and determined if the study (1) found 
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any applicable data and (2) used the data in their analysis. 
The findings are graphically represented in Table 1. The 
full text of each article was reviewed to determine if the 
authors indicated finding applicable data or using it. If 
this information was not explicitly provided in the arti-
cle, we reviewed the author’s data tables (when available) 
and verified the included references to determine if any 
of the data used for analysis was retrieved from a clini-
cal trials registry. A total of 12 studies [16–27] searched 
either ClinicalTrials.gov or the WHO-approved registries 
and one [22] of these reviews reported searches of both. 
Of these, two systematic reviews reported [16, 20] that 
applicable data were found, but neither of the systematic 
reviews used the data. Furthermore, 8 of the reviews did 
not clearly indicate whether or not data were found [17, 
19, 21–26] and it was not possible to determine whether 
or not the data were used in 1 of the reviews [22]. In 
each of these cases, the corresponding cells are marked 
“yellow”. With the collected data in hand, two major 
questions remained unanswered for the majority of the 
articles: (1) if the authors searched clinical trials registry 
data, did they find any relevant data? and (2) if relevant 
data were found, did they include the data in their analy-
sis? In an attempt to answer these questions, a contrib-
uting author (BC) contacted the corresponding authors 
of each of the publication included in Table  1 via email 
(see the “Availability of data and materials” section for 
the email template). Contacts attempts were made twice 
within a period of 14  days. We received a total of 4 (of 
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one applicable trial was found on a clinical trials registry, 
the trial was at the recruiting stage and did not have data 
available. The remaining three authors stated that data 
from clinical trials registries was not included because it 
was already published and included in the analysis data-
set, dataset was missing or no unpublished findings met 
their inclusion criteria.
Clinical trials registry search between 2007 and today
In 2006, the WHO established a set of 20 items that 
must be included for a clinical trial to register with the 
approved databases [28]. Among these items are require-
ments for submission of primary and key secondary trial 
outcomes. In an effort to make this data publically avail-
able, WHO also created the International Clinical Trials 
Registry Portal (ICTRP) [29], which can be searched by 
systematic reviewers for unpublished data. Similarly, the 
United States passed the Food and Drug Amendments 
Act of 2007 (FDAA) [30], setting a higher standard for 
clinical trial registration at ClinicalTrials.gov. To assess 
the effect these landmark decisions on use of clinical tri-
als registries, we analysed the frequency with which these 
registries were searched by year. Interestingly, although 
there was an increase in systematic reviews and meta-
analyses published since 2007, the proportion of these 
studies searching clinical trials registries did not appear 
to increase (Fig.  3). Because of indexing delays of pub-
lished articles by PubMed, only seven systematic reviews 
were retrieved from the year of 2015, which is likely an 
underrepresentation of the total number published that 
year. Hence, it is difficult to draw any reliable conclusions 
about the number of systematic reviews and meta-analy-
ses searching clinical trials registries that year.
Potential data from clinical trials
As described above and discussed in further detail 
below, reliability of systematic reviews and meta-anal-
yses in guiding clinical decision-making is dependent 
on retrieval of all applicable data. Studies published in 
other disciplines have previously shown that valuable 
unpublished data is available on clinical trials registries, 
providing support for the need to search clinical trials 
registries when designing and performing a systematic 
review [3, 8]. However, no study to date has attempted 
to determine the value of searching clinical trials regis-
tries in Pregnancy and Childbirth systematic reviews. 
Although it was not a primary outcome of this study, 
we searched the availability of data from clinical trials 
for 26 randomly selected systematic reviews. Clinicaltri-
als.gov (Table 2) was searched for trials with data appli-
cable to each of the study’s respective topic. Our search 
indicated that a number of clinical trials on the database 
did, in fact, hold several studies with available data (yel-
low highlights), which could have been used by the sys-
tematic reviewers. In fact, a total of 190 clinical trials 
with available data were not included (or mentioned) 
during the systematic review. For instance, a search of 
clinicaltrials.gov for keywords in the systematic review 
“Vitamin A and Carotenoids During Pregnancy and 
Maternal, Neonatal and Infant Health Outcomes: A Sys-
tematic Review And Meta-Analysis” returned eight clini-
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Fig. 2 Frequency of clinical trials registry search by systematic reviews and meta-analyses published in the top 20 pregnancy and childbirth jour-
nals
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NCT00363038, NCT00706004, NCT00493012, 
NCT00198822, NCT01198574), with a total of 61,228 
patients enrolled. Each of these trials contained data, 
which should have been considered for, and could have 
potentially been used in, the systematic review.
Discussion
The goal of this study was to determine the frequency of 
clinical trials registry searches of systematic reviews and 
meta-analyses published in the highest-ranking Preg-
nancy and Childbirth journals. Our findings indicate that 
clinical trials registries continue to be widely underused 
in this specialty. Systematic reviewers are not using regis-
tries as a means to limit publication bias.
Given the broad scope of disease processes and the 
delicacy with which many clinical decisions in maternity 
and foetal care must be approached, systematic reviews 
and meta-analyses play a particularly important role in 
this specialty. By assimilating the most relevant primary 
research, systematic reviews and meta-analyses in the 
Pregnancy and Childbirth literature can be a useful tool 
for choosing an intervention that prioritizes “practices 
that are effective and least invasive, with limited or no 
known harms whenever possible” [31]. A fitting exam-
ple is demonstrated in a systematic review performed by 
the Cochrane Collaboration Pregnancy and Childbirth 
Group, who summarized clinical trials assessing admin-
istration of corticosteroids to women at risk for pre-term 
birth [32]. Today, this routine intervention reduces infant 
mortality by 30–50 %.
Published in 1989, the book “Effective Care in Preg-
nancy and Childbirth” [33] was monumental in 
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increasing availability and awareness of randomized trial 
evidence to pregnancy and maternal care physicians 
around the world. Since then, evidence-based medicine 
has become increasingly important for clinicians prac-
ticing in these specialties. The first large study to reveal 
the extent to which systematic reviews and meta-analyses 
influence clinical care in maternal and foetal medicine 
was performed by Wilson and colleagues [34] in 2002. 
The authors measured improvement in compliance with 
evidence-based medical guidelines across hospitals in 
United Kingdom in areas involving tissue closure, corti-
costeroid use for women at risk of pre-term birth, anti-
biotic prophylaxis for Caesarean section, and approaches 
to complicated vaginal birth. The authors found that 
since 1988, there was an average increase in compliance 
of 72, 82, 77 and 56 %, respectively for these specialties.
Today, the sheer volume of systematic reviews and 
meta-analyses published in the pregnancy and child-
birth literature is remarkable. It is estimated that the 
majority (over 20 %) of all systematic reviews and meta-
analyses present in medical literature are published in 
gynaecology, pregnancy and childbirth specialties [35]. 
Although these estimates are based on publications by 
the Cochrane Collaboration, others have also found that 
publications in obstetrics and gynaecology journals com-
prise a large portion of systematic reviews available [36]. 
As such, it should come as no surprise that systematic 
reviews and meta-analysis in Pregnancy and Childbirth 
have shaped essential clinical decisions, such as timing 
of corticosteroid administration for women at risk for 
preterm birth [32], methods of labour induction [37], 
approaches to intrapartum anaesthesia [38, 39], inter-
ventions for postpartum complications [40] and more 
[41–45]. With increased availability and use of systematic 
reviews and meta-analyses in making clinical decisions, it 
is essential that the quality of these works be maintained 
at the highest level. The movement to standardize and 
improve the quality of systematic reviews and meta-anal-
yses in the obstetric literature has gained momentum in 
the past decade, as evidenced by the growing collection 
of publications on the topic [46–50]. Although increased 
standardization of systematic reviews and meta-analyses 
in the medical literature [51] has been improved, one 
aspect—methods to limit publication bias—continues to 
lag behind [6, 7, 9, 52–54].
As awareness of publication bias in systematic reviews 
increases [7, 55–58], we are only beginning to affirm the 
detrimental effects publication bias has on clinical prac-
tice [59–64]. In fact, a statement released in January 2016 
by the International Committee of Medical Journal Edi-
tors (ICMJE) justly noted that “there is an ethical obliga-
tion to responsibly share data generated by interventional 
clinical trials because participants put themselves at risk.” 
[65]. An increased number of studies are finding that 
2007 2008 2009 2010 2011 2012 2013 2014 2015
%Searched 0% 0% 7% 0% 3% 2% 7% 6% 14%
Searched 0 0 2 0 1 1 4 3 1
































Fig. 3 Temporal trend of clinical trials registry search by systematic reviews in the top 20 pregnancy and childbirth journals. The number (left vertical 
axis) of systematic reviews and meta-analyses searching (blue line) and not searching (orange line) clinical trials registries between 2007 and 2015. 
The grey bars represent the percentage (right vertical axis) of systematic reviews and meta-analyses that searched clinical trials registries for the given 
year
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systematic reviews across various specialties, such as psy-
chiatry [60, 62–64], oncology [59] and cardiorespiratory 
[61] may be providing erroneous conclusions as a result 
of publication bias.
This study has a number of limitations. For instance, 
we did not specifically examine the rates of trial registra-
tion by country or region. It is possible that registration 
rates differ between countries due to specific legisla-
tions. For example, passage of the FDA Amendments Act 
in the United States contributed to a sharp increase in 
trial registrations. In countries with no such legislation, 
trial registrations may be lower. The intent of our study 
was to examine rates of registry searching by system-
atic reviewers, and it is not known whether systematic 
reviewers from countries with such legislation in place 
would be more likely to search a clinical trials registry 
due to a greater awareness of their existence. This would 
be an interesting avenue for future research; however, 
such an investigation would be complicated by the num-
ber of international multi-center collaborations and the 
possibility for authors to register with a registry outside 
of their home country. Additionally, although it appears 
that for most of the studies clinical trials data was avail-
able, the actual inclusion criteria for the data from each 
trial would have been determined by the authors of the 
systematic review and hence, may not have been applica-
ble to the study. Even so, none of the authors from the 26 
randomly-selected reviews (see Table 2) reported search-
ing or finding clinical trials data.
Finally, it is interesting to note that although we found 
that by searching clinical trials registries, over 50 % of sys-
tematic reviews could have obtained additional data, only 
a small fraction of the trials available on these registries 
reported the data, and could thus be used without the 
need to retrieve the data (Table 2). As such, it is possible 
that majority of authors may be discouraged from search-
ing clinical trials registries, since the yield of available data 
is very low. If the case is such, we continue to strongly 
encourage the authors to search clinical trials regis-
tries for two reasons: (1) if time and monetary resources 
are an obstacle, it is still possible to set a filter to search 
only for trials, which contain data, hence, little effort is 
required to retrieve available data from trials registries 
and (2) it is possible to contact the research coordinator 
(whose contact information should always be listed on 
the study page) to ask for the missing data. Nonetheless, 
this may be a source of hesitation for authors and should 
thus be addressed in future research in order to perform 
a cost-benefit analysis for searching and attempting to 
retrieve the missing data from the registered clinical tri-
als. We also encourage systematic reviewers to include 
more descriptive statements when reporting their data 
sources. Specifically, when a systematic reviewer does 
not indicate the source of retrieved data (as found in 7 of 
the 12 reviews listed in Table 1), it’s not possible to deter-
mine if the source of data was a clinical trials registry or 
a database of published works. One possible solution is 
to use the PRISMA guidelines for reporting of systematic 
reviews, which includes a template flow diagram [15].
Conclusions
In conclusion, systematic reviewers in Pregnancy and 
Childbirth should search clinical trials registries to miti-
gate the implications of publication bias on the predicted 
efficacy of an intervention. Currently, the immediate 
consequences of publication bias on clinical decision-
making in Pregnancy and Childbirth have yet to be fully 
understood. There is, however, increasing evidence that 
publication bias is present in the primary research [4], as 
well as systematic reviews and meta-analyses [14, 46–50] 
within the specialty. To our knowledge, this is the first 
study to undertake an assessment of this magnitude on 
the topic of publication bias in systematic reviews and 
meta-analyses in Pregnancy and Childbirth literature.
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